Z-0556-2022 Class II Ongoing

Recalled by FEMSelect Ltd — Modi'in, N/A

FDA device recall Z-0556-2022 was initiated by FEMSelect Ltd on December 13, 2021 and is designated Class II. Reason for recall: Certain lots may not have been packaged wth the Channel Tube Limiter. The recall status is ongoing. Affected quantity: 141 units.

Recall Details

Product Type
Devices
Report Date
February 9, 2022
Initiation Date
December 13, 2021
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
141 units

Product Description

The EnPlace is a single use trans-vaginal pelvic floor repair system which enables delivery of a tissue anchor to the ligaments of the vaginal cavity. The anchors are pre-loaded inside the device shaft and are ready for use. A thimble is also supplied, as an accessory for the device, to be used as a guide channel for better handling of the EnPlace. Intended Use / Indications for Use: The EnPlace system is intended for attaching sutures to ligaments of the pelvic floor.

Reason for Recall

Certain lots may not have been packaged wth the Channel Tube Limiter.

Distribution Pattern

US Nationwide distribution in the state of Georgia.

Code Information

UDI (01)07290017 08201 1 (10) YYMMDDXX (11)YYMMDD (17)YYMMDD, Lot Numbers: 21072510 and 21072512.